A Study of Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Lap. Prostatectomy

NCT01661166 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Prostate Adenocarcinoma

Interventions

DRUG: Fesoterodine
DRUG: Placebo oral tablet

Sponsor

Abramson Cancer Center at Penn Medicine